Wolverine Asset Management’s Novavax NVAX Stock Holding History

Wolverine Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Sell	223,700 -100	-0%	-$906	0.02%	601
2025 Q4	$1.5M	Hold	223,800	–	–	0.01%	675
2025 Q3	$1.94M	Buy	223,800 +223,700	+223,700%	+$1.74M	0.01%	563
2025 Q2	$630	Buy	+100	New	+$662	﹤0.01%	1530
2025 Q1	–	Sell	-100	Closed	-$803	–	1714
2024 Q4	$803	Hold	100	–	–	﹤0.01%	1518
2024 Q3	$1.26K	Hold	100	–	–	﹤0.01%	1505
2024 Q2	$1.27K	Hold	100	–	–	﹤0.01%	1526
2024 Q1	$478	Sell	100 -50,400	-100%	-$234K	﹤0.01%	1564
2023 Q4	$242K	Hold	50,500	–	–	﹤0.01%	1023
2023 Q3	$366K	Sell	50,500 -215,000	-81%	-$1.72M	﹤0.01%	951
2023 Q2	$1.97M	Sell	265,500 -456,000	-63%	-$3.59M	0.02%	509
2023 Q1	$5M	Buy	721,500 +345,200	+92%	+$3.18M	0.06%	322
2022 Q4	$3.87M	Buy	376,300 +285,300	+314%	+$5.03M	0.04%	400
2022 Q3	$1.66M	Sell	91,000 -100	-0.1%	-$4.33K	0.02%	625
2022 Q2	$4.68M	Sell	91,100 -51,300	-36%	-$2.66M	0.05%	333
2022 Q1	$10.5M	Buy	142,400 +78,900	+124%	+$7.04M	0.1%	199
2021 Q4	$9.08M	Hold	63,500	–	–	0.08%	215
2021 Q3	$13.2M	Hold	63,500	–	–	0.11%	186
2021 Q2	$13.5M	Sell	63,500 -800	-1%	-$147K	0.1%	190
2021 Q1	$11.7M	Sell	64,300 -58,400	-48%	-$11.6M	0.1%	169
2020 Q4	$13.7M	Buy	122,700 +6,000	+5%	+$638K	0.1%	160
2020 Q3	$12.6M	Buy	116,700 +77,900	+201%	+$9.49M	0.11%	134
2020 Q2	$3.23M	Buy	38,800 +24,000	+162%	+$918K	0.03%	305
2020 Q1	$200K	Sell	14,800 -121,300	-89%	-$1.03M	﹤0.01%	890
2019 Q4	$541K	Sell	136,100 -1,000	-0.7%	-$4.34K	0.01%	766
2019 Q3	$688K	Buy	137,100 +11,100	+9%	+$60.8K	0.01%	694
2019 Q2	$738K	Buy	126,000 +118,600	+1,603%	+$933K	0.01%	746
2019 Q1	$81K	Sell	7,400 -825	-10%	-$26K	﹤0.01%	1145
2018 Q4	$302K	Buy	8,225 +4,605	+127%	+$178K	﹤0.01%	1158
2018 Q3	$136K	Sell	3,620 -740	-17%	-$20.8K	﹤0.01%	1246
2018 Q2	$116K	Buy	4,360 +100	+2%	+$3.38K	﹤0.01%	1174
2018 Q1	$178K	Buy	4,260 +705	+20%	+$28.3K	﹤0.01%	1165
2017 Q4	$88K	Hold	3,555	–	–	﹤0.01%	1195
2017 Q3	$81K	Buy	3,555 +3,070	+633%	+$68.7K	﹤0.01%	1125
2017 Q2	$11K	Sell	485 -1,535	-76%	-$30.1K	﹤0.01%	1212
2017 Q1	$51K	Sell	2,020 -17,035	-89%	-$468K	﹤0.01%	1015
2016 Q4	$480K	Sell	19,055 -3,785	-17%	-$110K	0.01%	683
2016 Q3	$950K	Buy	22,840 +8,200	+56%	+$1.06M	0.01%	577
2016 Q2	$2.13M	Buy	14,640 +14,586	+27,011%	+$1.67M	0.03%	427
2016 Q1	$191K	Buy	+54	New	+$5.79K	0.01%	671

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Asset Management's NVAX Position: Q1 2024 in Review

Wolverine Asset Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 22,767 shares — an estimated $106K sold.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and held it in 11 quarters. The position peaked at $2.43M in Q1 2023. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

Wolverine Asset Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
Wolverine Asset Management sold 22,767 Novavax shares in Q1 2024, an estimated $106K.
Wolverine Asset Management first reported a position in Novavax in Q4 2018 and held it in 11 quarters.
Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.